Market Pulse: Boston Sci: Stent trial shows less need for repeat procedure
14th Sep 2005, 12:52 GMT
Boston Scientific said after 's closing bell that a clinical trial for the Taxus Express2 stent system showed significantly reduced risk of artery re-narrowing 9 months after angioplasty for patients with complex coronary artery lesions, compared to bare-metal stents.
Latest news from Radiology News from myHealthcareNews.com:
- Genzyme increasing R&D presence in San Antonio area
- Eisai Breaks Ground for New Oncology Facility in Research Triangle Park
- Ashok Gupta, MD Joins the Physician Team at Desert Radiologists
- AMICAS Offers Free PACS Webinar for RSNA Attendees
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
- Groundbreaking for Cancer Center on Premier Healh Campus - Middletown
- BSD Medical Sends Message of Hope at Largest Conference of US Radiation Oncologists
- Volcano to Offer 7.5M Shares
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies.
- Adherex Reports Q3 2006 Financial Results